معرفی
Dr. Joseph Paul Eder is an Adjunct Professor at the Yale School of Medicine, affiliated with the Department of Medical Oncology and Hematology. He specializes in early drug development, immuno-oncology, and precision medicine. His research focuses on Phase I clinical trials, molecularly targeted therapies, and signal transduction pathways. Dr. Eder holds leadership roles in clinical programs at the Dana-Farber Cancer Institute and Yale Cancer Center.
Education & Training:
- M.D. from Georgetown University School of Medicine (1978)
- Residency at Georgetown University Hospital (1981–1982)
- Fellowships at Dana-Farber Cancer Institute, Beth Israel Hospital, and Georgetown University Hospital (1982–1985)
Research Interests:
- Early-phase clinical trials for cancer
- Immuno-oncology combinations
- Targeted therapies for drug resistance
- Genomic profiling in precision medicine
Key Contributions:
- Leadership in the DF/HCC Experimental Therapeutics Program
- Global clinical development of cancer therapies at AstraZeneca
- Advances in Phase I trial design and molecularly guided treatments
Awards: Listed in Who’s Who.
Labs/Teams: Active in the Yale Precision Medicine Tumor Board and Early Drug Development Program.
۰مقاله منتشرشده
